TRPM2 and pancreatic neoplasm: For example, the NORAD/miR-125a-3p/RhoA ceRNA network facilitates the invasion and metastasis of pancreatic cancer (Li et al., 2017), the TRPM2-AS/miR-612/FOXM1 ceRNA network promotes GC cell progression, invasion, and radioresistance (Xiao et al., 2020), while the MALAT1/miR-200b/E2F3 ceRNA network induces docetaxel resistance in LUAD treatment (Chen J. et al., 2019).